Back to BlackRock, Inc. BlackRock, Inc.

TVRDTVRD
5 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in TVARDI THERAPEUTICS INC COM

Yes. BlackRock holds 95,478 shares of TVRD (Tvardi Therapeutics), worth $181,408, as of its Q2 2026 13F filing. It reduced the position by 292,597 shares (-75.4%) from Q1 2026. BlackRock has held TVRD in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$181,408

Current Shares

95,478

Total Value Change

-$6.1M

Total Shares Change

-172,397

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
95,478
-75.4%
$181,4080.0%$1.90
0
2026-Q1
Decreased
388,075
-0.8%
$1.2M0.0%$3.18
0
2025-Q4
Increased
391,000
+18.5%
$1.7M0.0%$4.30
21
2025-Q3
Increased
329,914
+23.2%
$12.9M0.0%$38.97
34
2025-Q2
New
267,875
-
$6.2M0.0%$23.33
38

Other major holders of TVRD: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used